IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Iradimed Corp. (IRMD) Tops Q4 EPS by 12c; Guides Above
February 4, 2022 7:03 AM ESTIradimed Corp. (NASDAQ: IRMD) reported Q4 EPS of $0.33, $0.12 better than the analyst estimate of $0.21. Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.63 million.
GUIDANCE:
Iradimed Corp. sees Q1 2022 EPS of $0.20-$0.21. Iradimed Corp. sees Q1 2022... More
